Contribution of MUltiparametric Analysis in Bone Scintigraphy for the Characterisation of Solitary Bone Lesions

Recruiting N/A Interventional Study
Bone Lesion
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 90
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
68 (estimated)
Sponsor
Central Hospital, Nancy, France · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The hypothesis of the study is that non-invasive Single photon emission computed tomography (SPECT-CT) bone scintigraphy makes it possible to better characterize solitary bone lesions, in particular the exclusion of their malignancy in order to avoid unnecessary biopsy and possible complications for the patient.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Person, having received complete information on the organization of the research and having signed the informed consent and: * Age ≥ 18 years old. * Having read and understood the information document. * Affiliated to a social security scheme. * Patient with an indeterm…
Contacts

ACHRAF BAHLOUL, MD, MSc

383154003

a.bahloul@chru-nancy.fr

CONTACT

VERONIQUE ROCH, MSc

383154276

v.roch@chru-nancy.fr

CONTACT